LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.
May 6, 2021 (Children’s Health Defense) — A 50-year-old woman from the Canadian province of Alberta died from a rare blood clot condition after receiving the AstraZeneca-Oxford vaccine, the province’s chief medical officer of health said.
In a statement Tuesday, Dr. Deena Hinshaw said the woman died of vaccine-induced immune thrombotic thrombocytopenia (VITT). It was Canada’s second confirmed death of VITT linked to the vaccine.
Though extremely rare, VITT differs from a typical blood clot because it can cause both cerebral venous sinus thrombosis (CVST) — where veins that drain blood from the brain are obstructed –– and fatal bleeding.
According to CBC News, Canada has reported seven cases of blood clots following immunization with AstraZeneca, but public health officials maintain the benefits of the vaccine outweigh the potential risks.
In a statement Wednesday, Alberta Health said they will continue to administer AstraZeneca’s COVID vaccine. “This does not change the risk assessment previously communicated to Albertans.”
As The Defender reported April 7, European regulators found a “possible link” between AstraZeneca’s COVID vaccine and “very rare” blood clots, but concluded the benefits of the vaccine still outweigh the risks.
The European Medicines Agency (EMA) did not recommend restricting
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors